Measure of Acceptance of chRonic Visible sKin conditionS
NCT ID: NCT06103903
Last Updated: 2023-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2022-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Biological, Biometrological Parameters and Consumer Needs in Adult Subjects with Acne
NCT06841393
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
NCT06324695
The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
NCT07046039
A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions
NCT05084417
Vitiligo and Psychodrama Therapy
NCT05991596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigator will screen the patients and give them a link to complete the questionnaire (according to the age), that includes a pre-scale of acceptation of 50-55 items.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children aged 6-13 years
Children aged 6-13 years with a chronic skin visible disease
Questionnaire
Questionnaire according to age (6-13;14-17); the parents for minors and adults
Adolescents aged 14-17 years
Adolescents aged 14-17 years years with a chronic skin visible disease
Questionnaire
Questionnaire according to age (6-13;14-17); the parents for minors and adults
Adult patients
Adult patients aged 18 years and more with a chronic skin visible disease
Questionnaire
Questionnaire according to age (6-13;14-17); the parents for minors and adults
Parents of children aged 6 years and more
Parents of children aged 6 years and more with a chronic skin visible disease
Questionnaire
Questionnaire according to age (6-13;14-17); the parents for minors and adults
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire according to age (6-13;14-17); the parents for minors and adults
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Flat angioma
* Primary hypopigmentation and early vitiligo
* Primary hyperpigmentation
* Refractory alopecia areata or congenital alopecia
2. Persons concerned:
* Children (≥ 6 years old) suffering from one of the aforementioned pathologies
* Adults suffering from one of the above-mentioned pathologies
* Parents of children suffering from one of the aforementioned pathologies
* Parents of young adult patients if they live under the same roof
3. Oral agreement for each person (major/minor) and, where applicable, one of the holders of parental authority (minor)
Exclusion Criteria
2. Major psychiatric disorders
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
INSERM UMR 1246 SPHERE
UNKNOWN
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annabel MARUANI, MD-PhD
Role: STUDY_DIRECTOR
University Hospital of TOURS
Jean-Benoit HARDOUIN, MD-PhD
Role: STUDY_CHAIR
INSERM UMR 1246 SPHERE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital TOURS
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MARKS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.